BNTX

BioNTech SE - American Depositary Shares (BNTX)

About BioNTech SE - American Depositary Shares (BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Details

Daily high
$90.88
Daily low
$85.80
Price at open
$90.83
52 Week High
$124.00
52 Week Low
$79.52
Market cap
22.8B
Dividend yield
-
Volume
1.2M
Avg. volume
1.2M
P/E ratio
-11.56

BioNTech SE - American Depositary Shares News

Details

Daily high
$90.88
Daily low
$85.80
Price at open
$90.83
52 Week High
$124.00
52 Week Low
$79.52
Market cap
22.8B
Dividend yield
-
Volume
1.2M
Avg. volume
1.2M
P/E ratio
-11.56